Squarepoint Ops LLC Sangamo Therapeutics, Inc Transaction History

Squarepoint Ops LLC

$93.7 Billion
Q2 2025

A detailed history of Squarepoint Ops LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 625,034 shares of SGMO stock, worth $325,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares

625,034

Previous 10,801 5686.82%

Holding current value

$325,017

Previous $7,000 4714.29%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 27, 2025	BUY	$0.43 - $0.81 $264,120 - $497,528	614,233 Added 5686.82%	625,034 $337,000
Q2 2025 Aug 14, 2025	BUY	$0.43 - $0.81 $264,120 - $497,528	614,233 Added 5686.82%	625,034 $337,000
Q1 2025 Aug 27, 2025	SELL	$0.66 - $1.37 $405,393 - $841,499	-614,233 Reduced 98.27%	10,801 $7,000
Q1 2025 May 15, 2025	SELL	$0.66 - $1.37 $461,710 - $958,399	-699,562 Reduced 98.48%	10,801 $7,000
Q4 2024 Feb 14, 2025	BUY	$0.78 - $2.87 $554,083 - $2.04 Million	710,363 New	710,363 $724,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $12,343 - $25,921	41,146 New	41,146 $22,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $113,949 - $170,523	26,686 Added 173.39%	42,077 $206,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $29,129 - $55,151	-8,881 Reduced 36.59%	15,391 $64,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $126,942 - $189,807	24,272 New	24,272 $141,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $113,282 - $151,001	-12,573 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $436,140 - $542,066	-42,885 Reduced 77.33%	12,573 $150,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $217,817 - $341,341	-20,020 Reduced 26.52%	55,458 $695,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $120,894 - $238,121	13,098 Added 21.0%	75,478 $1.18 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $585,124 - $778,502	62,380 New	62,380 $589,000
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $330,955 - $630,468	-53,294 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $265,503 - $465,288	-52,575 Reduced 49.66%	53,294 $339,000
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $553,034 - $805,790	-68,871 Reduced 39.41%	105,869 $886,000
Q3 2019 Nov 14, 2019	BUY	$9.05 - $12.22 $1.02 Million - $1.38 Million	113,232 Added 184.09%	174,740 $1.58 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $213,176 - $317,449	24,363 Added 65.59%	61,508 $662,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $134,860 - $223,777	17,469 Added 88.78%	37,145 $354,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $154,765 - $270,148	-16,274 Reduced 45.27%	19,676 $226,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $357,570 - $521,970	-27,400 Reduced 43.25%	35,950 $609,000
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $795,232 - $1.13 Million	-57,211 Reduced 47.45%	63,350 $900,000
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $1.3 Million - $2.05 Million	77,725 Added 181.45%	120,561 $2.29 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $496,897 - $743,204	42,836	42,836 $703,000

Others Institutions Holding SGMO

# of Institutions

125

Shares Held

50.6M

Call Options Held

1.1M

Put Options Held

789K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $81.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Sangamo Therapeutics, Inc Transaction History